Suppr超能文献

用非标准体液填补缺口。

Filling in the gaps with non-standard body fluids.

作者信息

Lo Sheng-Ying, Saifee Nabiha H, Mason Brook O, Greene Dina N

机构信息

Department of Laboratory Medicine, Chemistry Division, University of Washington, Seattle, WA, USA.

出版信息

Pract Lab Med. 2016 Mar 16;5:24-31. doi: 10.1016/j.plabm.2016.03.003. eCollection 2016 Aug 1.

Abstract

OBJECTIVES

Body fluid specimens other than serum, plasma or urine are generally not validated by manufacturers, but analysis of these non-standard fluids can be important for clinical diagnosis and management. Laboratories, therefore, rely on the published literature to better understand the validation and implementation of such tests. This study utilized a data-driven approach to determine the clinical reportable range for 11 analytes, evaluated a total bilirubin assay, and assessed interferences from hemolysis, icterus, and lipemia in non-standard fluids.

DESIGN AND METHODS

Historical measurements in non-standard body fluids run on a Beckman Coulter DxC800 were used to optimize population-specific clinical reportable ranges for albumin, amylase, creatinine, glucose, lactate dehydrogenase, lipase, total bilirubin, total cholesterol, total protein, triglyceride and urea nitrogen run on the Beckman Coulter AU680. For these 11 analytes, interference studies were performed by spiking hemolysate, bilirubin, or Intralipid® into abnormal serous fluids. Precision, accuracy, linearity, and stability of total bilirubin in non-standard fluids was evaluated on the Beckman Coulter AU680 analyzer.

RESULTS

The historical non-standard fluid results indicated that in order to report a numeric result, 4 assays required no dilution, 5 assays required onboard dilutions and 2 assays required both onboard and manual dilutions. The AU680 total bilirubin assay is suitable for clinical testing of non-standard fluids. Interference studies revealed that of the 11 total AU680 analyte measurements on non-standard fluids, lipemia affected 1, icterus affected 3, and hemolysis affected 5.

CONCLUSIONS

Chemistry analytes measured on the AU680 demonstrate acceptable analytical performance for non-standard fluids. Common endogenous interference from lipemia, icterus, and hemolysis (LIH) are observed and flagging rules based on LIH indices were developed to help improve the clinical interpretation of results.

摘要

目的

除血清、血浆或尿液之外的体液样本通常未得到制造商的验证,但对这些非标准体液进行分析对于临床诊断和管理可能很重要。因此,实验室依赖已发表的文献来更好地了解此类检测的验证和实施情况。本研究采用数据驱动的方法来确定11种分析物的临床报告范围,评估总胆红素检测,并评估非标准体液中溶血、黄疸和脂血的干扰情况。

设计与方法

利用在贝克曼库尔特DxC800上检测的非标准体液的历史测量数据,来优化在贝克曼库尔特AU680上检测的白蛋白、淀粉酶、肌酐、葡萄糖、乳酸脱氢酶、脂肪酶、总胆红素、总胆固醇、总蛋白、甘油三酯和尿素氮的特定人群临床报告范围。对于这11种分析物,通过向异常浆液性体液中加入溶血产物、胆红素或英脱利匹特®进行干扰研究。在贝克曼库尔特AU680分析仪上评估非标准体液中总胆红素的精密度、准确度、线性和稳定性。

结果

非标准体液的历史检测结果表明,为了报告数值结果,4种检测无需稀释,5种检测需要仪器自动稀释,2种检测需要仪器自动稀释和手动稀释。AU680总胆红素检测适用于非标准体液的临床检测。干扰研究表明,在对非标准体液进行的11项AU680分析物总测量中,脂血影响1项,黄疸影响3项,溶血影响5项。

结论

在AU680上检测的化学分析物对非标准体液显示出可接受的分析性能。观察到脂血、黄疸和溶血(LIH)常见的内源性干扰,并制定了基于LIH指数的警示规则,以帮助改善结果的临床解读。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f41/5574517/53131391ccd5/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验